ProCE Banner Activity

Immune Checkpoint Inhibitors for Hepatobiliary Cancers

Slideset Download
Download this slideset for expert perspectives on best practices and emerging strategies in using immune checkpoint inhibitors for patients with hepatocellular carcinoma and biliary tract cancers.

Released: January 27, 2021

Expiration: January 26, 2022

No longer available for credit.

Share

Faculty

Amit G. Singal

Amit G. Singal, MD, MS

Chief of Hepatology
Medical Director
, Liver Tumor Program
Professor, Department of Internal Medicine
UT Southwestern Medical Center
Dallas, Texas

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca

Faculty Disclosure

Primary Author

Amit G. Singal, MD, MS

Chief of Hepatology
Medical Director
, Liver Tumor Program
Professor, Department of Internal Medicine
UT Southwestern Medical Center
Dallas, Texas